Montelukast reverses ß2-adrenoceptor tolerance in airway smooth muscle and shows a synergic effect in vivo
I. Cerqua (Napoli, Italy), E. Granato (Napoli, Italy), M. Muscarà (São Paulo, Brazil), G. Cirino (Napoli, Italy), B. Severino (Napoli, Italy), R. Pavese (Salerno, Italy), A. Petti (Salerno, Italy), G. Caliendo (Napoli, Italy), F. Roviezzo (Napoli, Italy)
Source: International Congress 2022 – Clinical and translational studies of asthma and COPD: novel mechanisms
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Cerqua (Napoli, Italy), E. Granato (Napoli, Italy), M. Muscarà (São Paulo, Brazil), G. Cirino (Napoli, Italy), B. Severino (Napoli, Italy), R. Pavese (Salerno, Italy), A. Petti (Salerno, Italy), G. Caliendo (Napoli, Italy), F. Roviezzo (Napoli, Italy). Montelukast reverses ß2-adrenoceptor tolerance in airway smooth muscle and shows a synergic effect in vivo. 2257
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|